Terns Pharmaceuticals Statistics

Total Valuation

TERN has a market cap or net worth of $382.89 million. The enterprise value is $142.66 million.

Market Cap	382.89M
Enterprise Value	142.66M

Important Dates

The last earnings date was Monday, May 13, 2024, before market open.

Earnings Date	May 13, 2024
Ex-Dividend Date	n/a

Share Statistics

TERN has 64.68 million shares outstanding. The number of shares has increased by 6.62% in one year.

Shares Outstanding	64.68M
Shares Change (YoY)	+6.62%
Shares Change (QoQ)	+2.84%
Owned by Insiders (%)	1.78%
Owned by Institutions (%)	114.14%
Float	26.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.62
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 27.85, with a Debt / Equity ratio of 0.00.

Current Ratio	27.85
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -35.50% and return on invested capital (ROIC) is -43.79%.

Return on Equity (ROE)	-35.50%
Return on Assets (ROA)	-33.80%
Return on Capital (ROIC)	-43.79%
Revenue Per Employee	n/a
Profits Per Employee	-$1.38M
Employee Count	66
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TERN has paid $276,000 in taxes.

Income Tax	276,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.88% in the last 52 weeks. The beta is -0.50, so TERN's price volatility has been lower than the market average.

Beta (1Y)	-0.50
52-Week Price Change	-42.88%
50-Day Moving Average	5.80
200-Day Moving Average	5.75
Relative Strength Index (RSI)	55.30
Average Volume (30 Days)	958,958

Short Selling Information

The latest short interest is 4.49 million, so 6.94% of the outstanding shares have been sold short.

Short Interest	4.49M
Short Previous Month	4.40M
Short % of Shares Out	6.94%
Short % of Float	16.66%
Short Ratio (days to cover)	5.04

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-103.85M
Pretax Income	-90.78M
Net Income	-91.06M
EBITDA	-89.88M
EBIT	-90.78M
Earnings Per Share (EPS)	-$1.26

Full Income Statement

Balance Sheet

The company has $240.65 million in cash and $427,000 in debt, giving a net cash position of $240.23 million or $3.71 per share.

Cash & Cash Equivalents	240.65M
Total Debt	427,000
Net Cash	240.23M
Net Cash Per Share	$3.71
Equity / Book Value	236.72M
Book Value Per Share	3.66
Working Capital	237.07M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$75.81 million and capital expenditures -$81,000, giving a free cash flow of -$75.89 million.

Operating Cash Flow	-75.81M
Capital Expenditures	-81,000
Free Cash Flow	-75.89M
FCF Per Share	-$1.02

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TERN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.62%
Shareholder Yield	-6.62%
Earnings Yield	-23.78%
FCF Yield	-19.82%

Analyst Forecast

The average price target for TERN is $14.94, which is 153.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.94
Price Target Difference	153.22%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-4.10%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2